BeiGene
ONC
#668
Rank
ยฃ22.36 B
Marketcap
ยฃ192.27
Share price
2.82%
Change (1 day)
72.27%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (ONC)

Market cap: ยฃ22.36 Billion

As of April 2025 BeiGene has a market cap of ยฃ22.36 Billion. This makes BeiGene the world's 668th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ22.36 B37.04%
2024ยฃ16.32 B5.47%
2023ยฃ15.47 B-26.4%
2022ยฃ21.02 B2.11%
2021ยฃ20.58 B18.57%
2020ยฃ17.36 B122.85%
2019ยฃ7.79 B18.35%
2018ยฃ6.58 B99.94%
2017ยฃ3.29 B237.3%
2016ยฃ0.97 B

End of Day market cap according to different sources

On Apr 23rd, 2025 the market cap of BeiGene was reported to be:

ยฃ19.95 Billion
by Nasdaq info icon info icon
ยฃ21.24 Billion
by CompaniesMarketCap info icon info icon
ยฃ21.24 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ15.69 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.86 B-96.11%๐Ÿ‡บ๐Ÿ‡ธ USA